- Home
- NRXS vs PT Comparison
NRXS vs PT Comparison
Compare NRXS & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- PT
- Stock Information
- Founded
- NRXS 2011
- PT 2012
- Country
- NRXS United States
- PT China
- Employees
- NRXS N/A
- PT N/A
- Industry
- NRXS
- PT Computer Software: Programming Data Processing
- Sector
- NRXS
- PT Technology
- Exchange
- NRXS Nasdaq
- PT Nasdaq
- Market Cap
- NRXS 13.0M
- PT 15.2M
- IPO Year
- NRXS 2023
- PT 2018
- Fundamental
- Price
- NRXS $2.60
- PT $0.95
- Analyst Decision
- NRXS Strong Buy
- PT
- Analyst Count
- NRXS 1
- PT 0
- Target Price
- NRXS $7.00
- PT N/A
- AVG Volume (30 Days)
- NRXS 137.3K
- PT 12.6K
- Earning Date
- NRXS 08-08-2025
- PT 07-15-2025
- Dividend Yield
- NRXS N/A
- PT N/A
- EPS Growth
- NRXS N/A
- PT N/A
- EPS
- NRXS N/A
- PT N/A
- Revenue
- NRXS $2,934,945.00
- PT $4,814,566.00
- Revenue This Year
- NRXS $138,883.78
- PT N/A
- Revenue Next Year
- NRXS $118.59
- PT N/A
- P/E Ratio
- NRXS N/A
- PT N/A
- Revenue Growth
- NRXS 27.52
- PT N/A
- 52 Week Low
- NRXS $1.33
- PT $0.76
- 52 Week High
- NRXS $6.20
- PT $1.15
- Technical
- Relative Strength Index (RSI)
- NRXS 52.91
- PT 60.01
- Support Level
- NRXS $2.32
- PT $0.89
- Resistance Level
- NRXS $2.65
- PT $0.95
- Average True Range (ATR)
- NRXS 0.15
- PT 0.06
- MACD
- NRXS -0.01
- PT 0.01
- Stochastic Oscillator
- NRXS 78.05
- PT 100.00
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About PT Pintec Technology Holdings Limited
Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.